B Group, Inc.
20 holdingsFiling period: 2026-03-31Current AUM: $149.6Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ADMA | ADMA BIOLOGICS INC | 3.21M | $28.9M | $27.1M | 18.14% | +750.0K | 2026-03-31 |
| 2 | PALI | PALISADE BIO INC | 11.41M | $20.0M | $21.6M | 14.46% | +6.91M | 2026-03-31 |
| 3 | PRAX | PRAXIS PRECISION MEDICINES I | 33.2K | $10.7M | $10.2M | 6.84% | -- | 2026-03-31 |
| 4 | CLLS | CELLECTIS S A | 3.28M | $10.4M | $9.0M | 6.03% | -- | 2026-03-31 |
| 5 | ZLAB | ZAI LAB LTD | 450.6K | $8.5M | $8.2M | 5.50% | +50.6K | 2026-03-31 |
| 6 | TSHA | TAYSHA GENE THERAPIES INC | 1.80M | $8.0M | $10.6M | 7.05% | -- | 2026-03-31 |
| 7 | NRXP | NRX PHARMACEUTICALS INC | 3.00M | $6.4M | $9.4M | 6.32% | -- | 2026-03-31 |
| 8 | GPCR | STRUCTURE THERAPEUTICS INC | 127.5K | $6.1M | $6.1M | 4.09% | +37.5K | 2026-03-31 |
| 9 | IOVA | IOVANCE BIOTHERAPEUTICS INC | 1.50M | $5.3M | $6.1M | 4.08% | -- | 2026-03-31 |
| 10 | SYRE | SPYRE THERAPEUTICS INC | 100.0K | $5.0M | $9.8M | 6.57% | -- | 2026-03-31 |
| 11 | DRUG | BRIGHT MINDS BIOSCIENCES INC | 67.5K | $4.9M | $4.9M | 3.31% | -- | 2026-03-31 |
| 12 | ASMB | ASSEMBLY BIOSCIENCES INC | 175.7K | $4.9M | $4.4M | 2.95% | -- | 2026-03-31 |
| 13 | AURA | AURA BIOSCIENCES INC | 597.6K | $4.0M | $4.2M | 2.80% | +25.0K | 2026-03-31 |
| 14 | ORKA | ORUKA THERAPEUTICS INC | 75.0K | $3.7M | $7.2M | 4.84% | -- | 2026-03-31 |
| 15 | SGHT | SIGHT SCIENCES INC | 970.0K | $3.7M | $5.1M | 3.41% | +50.0K | 2026-03-31 |
| 16 | RARE | ULTRAGENYX PHARMACEUTICAL IN | 135.0K | $2.8M | $3.4M | 2.25% | -- | 2026-03-31 |
| 17 | APGE | APOGEE THERAPEUTICS INC | 7.5K | $631K | $1.0M | 0.67% | -12,500 | 2026-03-31 |
| 18 | FHTX | FOGHORN THERAPEUTICS INC | 102.0K | $487K | $462K | 0.31% | -- | 2026-03-31 |
| 19 | SLNO | SOLENO THERAPEUTICS INC | 7.5K | $251K | $251K | 0.17% | -- | 2026-03-31 |
| 20 | REPL | REPLIMUNE GROUP INC | 26.0K | $198K | $290K | 0.19% | -24,000 | 2026-03-31 |
← Scroll →